GLP-1 Weight Loss Timeline: Week by Week

The GLP-1 weight loss timeline is a slow build, not a fast drop: most people see weight start to move within the first one to two months, the steepest loss happens roughly between months four and nine as the dose climbs, and weight tends to peak and plateau somewhere around 12 to 18 months. The reason it is gradual is the dosing itself. GLP-1 medications like semaglutide and tirzepatide are titrated upward slowly to limit nausea, so the early weeks are about reaching an effective dose, not maximum results. Here is the realistic GLP-1 weight loss timeline, week by week and month by month, and what changes it.

The GLP-1 weight loss timeline at a glance

Rough trajectory based on the major trials. Cumulative loss is illustrative; individual results vary widely.

Time	Dose phase	What is happening	Typical cumulative loss
Weeks 1 to 4	Starting dose	Body adjusts, side effects settle, little weight change	0 to 2%
Months 2 to 3	Dose increases	Appetite drops noticeably, loss begins	3 to 6%
Months 4 to 9	Climbing to maintenance	Steepest, most consistent loss	7 to 15%
Months 9 to 18	Maintenance	Loss slows, approaches a new set point	Peak (varies by drug)

Weeks 1 to 4: starting out

The first month is about tolerance, not weight. You start at the lowest dose, which is deliberately too low to do much, precisely so your gut can adjust. Nausea and other side effects are most likely now and during each later increase. Some people lose a little weight from reduced appetite or water shifts, but many see almost nothing on the scale, and that is normal and expected. Do not judge the medication by month one. We walk through this in detail in your first month on a GLP-1, and the dose steps in the semaglutide dosing schedule.

Months 2 to 3: it starts working

As the dose steps up, most people notice the real signature of these drugs: appetite and food noise quiet down, portions shrink without much effort, and the scale begins to move. This is when many people first believe the medication is working. Weight loss in this phase is often a few percent of body weight, building momentum into the steeper stretch ahead. Pairing it with adequate protein and activity from the start protects muscle and improves the quality of the loss, covered in a high-protein meal plan.

Months 4 to 9: the steepest stretch

This is where the bulk of GLP-1 weight loss happens. As you reach and tolerate the higher maintenance doses, loss tends to be at its most consistent, and this is the window that produces the headline trial numbers. How far you go depends heavily on the drug: in the trials, semaglutide reached about 14.9% mean weight loss and tirzepatide up to about 20.9%, with the curves still descending through this period. The full breakdown by drug is in our GLP-1 weight loss results index, and how to set a target in realistic weight loss goals.

Months 9 to 18: peak and plateau

Weight loss does not continue forever. Somewhere around 12 to 18 months, most people approach a new, lower set point and the scale levels off. A plateau here is normal and expected, not a failure or a sign the drug stopped working; it usually means intake and energy needs have rebalanced at the new weight. If the plateau comes much earlier or feels premature, it is worth reviewing dose, protein, and activity with a clinician, which we cover in the weight loss plateau guide.

How to make the most of each phase

The timeline is not just something that happens to you; a few habits shape how far and how cleanly you go.

• Weeks 1 to 4: focus on tolerating the dose, not the scale. Eat smaller, lower-fat meals, hydrate, and build the protein habit early so it is automatic later.
• Months 2 to 9: this is the window that counts. Hit a protein target at every meal to protect muscle, add resistance training two to three times a week, and do not under-eat to speed things up, which mostly costs you muscle.
• Plateau and maintenance: treat the plateau as a new baseline, not a wall. Keep the protein and training going, and review dose with your clinician if it came early.

Two mistakes stretch or stall the timeline. The first is stopping or skipping doses during the early side-effect weeks, which resets the adjustment process. The second is eating so little that the body loses muscle and metabolism drops faster than it should, covered in preserving muscle during weight loss. Done right, the same medication delivers a higher-quality result over the same months.

Is a slow timeline a problem?

Usually not. A gradual curve is the healthy one: faster is not better when the cost is muscle loss, gallstones, and rebound. The trials that produced the largest, most durable results ran over 12 to 18 months, not weeks. If your loss is genuinely stalled for many weeks despite a maintenance dose, good protein, and activity, that is worth a clinician conversation about dose or the specific drug. But a steady few pounds a month that adds up over a year is exactly what success looks like with these medications.

What changes your timeline

Two people on the same drug can have very different curves. The biggest factors:

• Which drug and dose: tirzepatide tends to take off more than semaglutide, and reaching the higher doses matters.
• How long you stay on it: the trials ran 68 to 72 weeks; stopping early leaves results on the table.
• Protein and resistance training: protect muscle, which keeps the loss high-quality and supports metabolism.
• Starting weight and biology: set point, genetics, and starting BMI all shift the curve.
• Tolerance: if side effects force a slower titration, the timeline stretches out.

Maintenance: staying there

The timeline does not really end, because GLP-1 weight loss largely depends on continued treatment. Trials of stopping show much of the lost weight returns over the following year, so most people move from a losing phase into an ongoing maintenance phase rather than finishing a course. Planning that maintenance, including whether and how to ever come off, is its own decision, covered in GLP-1 maintenance dosing and weight regain after stopping.